The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A Beneficial Role for Immunoglobulin E in Host Defense against Honeybee Venom
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They also mediate protection from venoms produced by a range of animals, including snakes and bees. 5 , 6 , 7”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [6]
In the citing paper
“On the other hand, mast cells can also be protective, for example against Staphylococcus, honeybee, and snake venom. 1 , 5 , 6 , 7”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [6]
In the citing paper
“In adults, mast cells have important functions in protective immunity from certain bacteria, 1 helminths 2 , 3 , 4 and animal venoms. 6 , 7”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [6]
In the citing paper
“in mice surviving an initial encounter with venom, acquired type 2 immune responses, IgE antibodies, the high affinity IgE receptor (FcεRI), and mast cells can contribute to acquired resistance to the lethal effects of both honeybee venom and Russell’s”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [96]
In the citing paper
“We also found that genetically IgE-deficient mice [97] could not develop acquired immunity to honeybee venom, even though they developed a robust IgG1 antibody response to the venom [96].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [96]
In the citing paper
“Subsequently, we found that the acquired enhanced resistance to Russell’s viper venom (RVV) which we observed in mice that had developed type 2 immune responses to that venom [96] also was highly dependent on IgE (Fig. 5) and FcεRI (see Fig. 4, A–E in ref. [105]), and could be effectively transferred by immune serum into normal mice (see Fig. 3, F–J in ref. [105]) but not into C57BL/6-Cpa3-Cre;Mcl”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [96]
In the citing paper
“Taken together, these two initial studies [96, 104] support the hypothesis that one physiological function of IgE is to protect the host against noxious substances.”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [96]
In the citing paper
“We also showed that “immune serum” from WT mice could passively transfer enhanced resistance to honeybee venom to naïve IgE-deficient mice, unless such “immune serum” was first treated to neutralize IgE or impair its ability to bind to FcεRI [96].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [96]
In the citing paper
“Finally, we revealed that naïve genetically mast cell-deficient C57BL/6-KitW-sh/KitW-sh or C57BL/6-Cpa3-Cre+-Mcl-1fl/fl mice which received immune serum from honeybee venom-immunized C57BL/6 WT mice actually exhibited worse survival after challenge with a high dose of honeybee venom than did mast cell-deficient mice which had received serum from PBS mock-immunized C57BL/6 WT mice [96].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [96]
In the citing paper
“Our evidence showed that IgE antibodies were the critical elements of the acquired host resistance to honeybee or Russell’s viper venom.”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [96]
In the citing paper
“We found that, in mice, IgE-associated type 2 immune responses against honeybee venom or Russell’s viper venom were able to increase significantly host resistance to challenge with potentially lethal doses of those venoms [96].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [96]
In the citing paper
“We found that most or all of the acquired resistance induced in mice by a single exposure to honeybee venom was transferable to naïve mice with only 250 microliters of serum from honeybee venom-immunized mice [96].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799
Self-citationTHE HIGH-AFFINITY I g E RECEPTOR (FcεRI): From Physiology to Pathology
Kinet, J.-P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.931 · Cited by 968
Research works printed but not linked: 47
- Akahoshi, 2011, Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice, J. Clin. Invest., 121, 4180, 10.1172/JCI46139 · DOI · Paper page
- Amiri, 1994, Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon gamma knockout mice, J. Exp. Med., 180, 43, 10.1084/jem.180.1.43 · DOI · Paper page
- Ando, 1993, J. Clin. Invest., 92, 1639, 10.1172/JCI116749 · DOI
- Annila, 2000, Bee venom allergy, Clin. Exp. Allergy, 30, 1682, 10.1046/j.1365-2222.2000.00885.x · DOI · Paper page
- Antonicelli, 2002, Epidemiology of Hymenoptera allergy, Curr. Opin. Allergy Clin. Immunol., 2, 341, 10.1097/00130832-200208000-00008 · DOI · Paper page
- Artis, 2012, Forum: Immunology: Allergy challenged, Nature, 484, 458, 10.1038/484458a · DOI
- Biló, 2005, Diagnosis of Hymenoptera venom allergy, Allergy, 60, 1339, 10.1111/j.1398-9995.2005.00963.x · DOI · Paper page
- Bruhns, 2012, Properties of mouse and human IgG receptors and their contribution to disease models, Blood, 119, 5640, 10.1182/blood-2012-01-380121 · DOI · Paper page
- Charavejasarn, 1975, Reactions of anti-bee venom mouse reagins and other antibodies with related antigens, Int. Arch. Allergy Appl. Immunol., 48, 691, 10.1159/000231356 · DOI · Paper page
- Finkelman, 2007, Anaphylaxis: lessons from mouse models, J. Allergy Clin. Immunol., 120, 506, 10.1016/j.jaci.2007.07.033 · DOI · Paper page
- Finkelman, 2004, Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites, Immunol. Rev., 201, 139, 10.1111/j.0105-2896.2004.00192.x · DOI · Paper page
- Fitzsimmons, 2009, Survival of the fittest: allergology or parasitology?, Trends Parasitol., 25, 447, 10.1016/j.pt.2009.07.004 · DOI · Paper page
- Haak-Frendscho, 1998, Anti-immunoglobulin E antibody treatment blocks histamine release and tissue contraction in sensitized mice, Immunology, 94, 115, 10.1046/j.1365-2567.1998.00478.x · DOI · Paper page
- Habermann, 1972, Bee and wasp venoms, Science, 177, 314, 10.1126/science.177.4046.314 · DOI · Paper page
- Higginbotham, 1971, The significance of the mast cell response to bee venom, J. Immunol., 106, 233, 10.4049/jimmunol.106.1.233 · DOI · Paper page
- Holgate, 2008, Treatment strategies for allergy and asthma, Nat. Rev. Immunol., 8, 218, 10.1038/nri2262 · DOI
- Ishizaka, 1986, Biological properties of a recombinant human immunoglobulin ε-chain fragment, Proc. Natl. Acad. Sci. USA, 83, 8323, 10.1073/pnas.83.21.8323 · DOI
- Jarisch, 1979, IgE antibodies to bee venom, phospholipase A, melittin and wasp venom, Clin. Allergy, 9, 535, 10.1111/j.1365-2222.1979.tb02518.x · DOI · Paper page
- Kawakami, 2005, Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance, J. Immunol., 175, 4167, 10.4049/jimmunol.175.7.4167 · DOI · Paper page
- Lilla, 2011, Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice, Blood, 118, 6930, 10.1182/blood-2011-03-343962 · DOI · Paper page
- Meiler, 2008, In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure, J. Exp. Med., 205, 2887, 10.1084/jem.20080193 · DOI · Paper page
- Metz, 2006, Mast cells can enhance resistance to snake and honeybee venoms, Science, 313, 526, 10.1126/science.1128877 · DOI · Paper page
- Miyajima, 1997, Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII, J. Clin. Invest., 99, 901, 10.1172/JCI119255 · DOI
- Mukherje, 2000, Some biochemical properties of Russell’s viper (Daboia russelli) venom from Eastern India: correlation with clinico-pathological manifestation in Russell’s viper bite, Toxicon, 38, 163, 10.1016/S0041-0101(99)00125-7 · DOI · Paper page
- Müller, 2005, Bee venom allergy in beekeepers and their family members, Curr. Opin. Allergy Clin. Immunol., 5, 343, 10.1097/01.all.0000173783.42906.95 · DOI · Paper page
- Oettgen, 1999, IgE in asthma and atopy: cellular and molecular connections, J. Clin. Invest., 104, 829, 10.1172/JCI8205 · DOI · Paper page
- Oettgen, 1994, Active anaphylaxis in IgE-deficient mice, Nature, 370, 367, 10.1038/370367a0 · DOI · Paper page
- Ozdemir, 2011, Mechanisms of immunotherapy to wasp and bee venom, Clin. Exp. Allergy, 41, 1226, 10.1111/j.1365-2222.2011.03812.x · DOI · Paper page
- Palm, 2012, Allergic host defences, Nature, 484, 465, 10.1038/nature11047 · DOI · Paper page
- Paul, 2010, How are TH2-type immune responses initiated and amplified?, Nat. Rev. Immunol., 10, 225, 10.1038/nri2735 · DOI
- Pawankar, 2012, Allergic diseases and asthma: a major global health concern, Curr. Opin. Allergy Clin. Immunol., 12, 39, 10.1097/ACI.0b013e32834ec13b · DOI
- Piliponsky, 2010, Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice, Am. J. Pathol., 176, 926, 10.2353/ajpath.2010.090342 · DOI
- Portier, 1902, De l’action anaphylactique de certains venims, C. R. Soc. Biol., 54, 170
- Profet, 1991, The function of allergy: immunological defense against toxins, Q. Rev. Biol., 66, 23, 10.1086/417049 · DOI · Paper page
- Prouvost-Danon, 1977, Effect of heating at 56 degrees C on mouse IgE antibodies, Immunochemistry, 14, 81, 10.1016/0019-2791(77)90284-1 · DOI · Paper page
- Pulendran, 2012, New paradigms in type 2 immunity, Science, 337, 431, 10.1126/science.1221064 · DOI · Paper page
- Reimers, 2000, Are anaphylactic reactions to snake bites immunoglobulin E-mediated?, Clin. Exp. Allergy, 30, 276, 10.1046/j.1365-2222.2000.00697.x · DOI
- Risch, 2009, Snake venomics of the Siamese Russell’s viper (Daboia russelli siamensis) — relation to pharmacological activities, J. Proteomics, 72, 256, 10.1016/j.jprot.2009.01.006 · DOI · Paper page
- Rivera, 2008, New insights on mast cell activation via the high affinity receptor for IgE, Adv. Immunol., 98, 85, 10.1016/S0065-2776(08)00403-3 · DOI · Paper page
- Saelinger, 1974, Hypersensitivity responses to bee venom and the mellitin, Int. Arch. Allergy Appl. Immunol., 46, 28, 10.1159/000231110 · DOI · Paper page
- Schmidt, 1995, Toxinology of venoms from the honeybee genus Apis, Toxicon, 33, 917, 10.1016/0041-0101(95)00011-A · DOI
- Schneider, 2007, Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin, J. Exp. Med., 204, 2629, 10.1084/jem.20071262 · DOI · Paper page
- Simpson, 2007, Snakes of medical importance in India: is the concept of the “Big 4” still relevant and useful?, Wilderness Environ. Med., 18, 2, 10.1580/06-WEME-CO-023R1.1 · DOI
- Stetson, 2004, Th2 cells: orchestrating barrier immunity, Adv. Immunol., 83, 163, 10.1016/S0065-2776(04)83005-0 · DOI · Paper page
- Strait, 2006, IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking, J. Clin. Invest., 116, 833, 10.1172/JCI25575 · DOI · Paper page
- Theakston, 2003, Report of a WHO workshop on the standardization and control of antivenoms, Toxicon, 41, 541, 10.1016/S0041-0101(02)00393-8 · DOI
- Wadee, 1987, Development of specific IgE antibodies after repeated exposure to snake venom, J. Allergy Clin. Immunol., 80, 695, 10.1016/0091-6749(87)90289-2 · DOI · Paper page
Cited by
Sorted by citations
Mast cells and IgE in defense against venoms: Possible “good side” of allergy?
Galli, S. J., Starkl, P., Marichal, T., & Tsai, M. (2016) · Allergology International · doi:10.1016/j.alit.2015.09.002 · Cited by 73
Self-citationMast cell ontogeny: From fetal development to life‐long health and disease
Chia, S. L., Kapoor, S., Carvalho, C., Bajénoff, M., & Gentek, R. (2023) · Immunological Reviews · doi:10.1111/imr.13191 · Cited by 60
Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy
Galli, S. J., Metz, M., Starkl, P., Marichal, T., & Tsai, M. (2020) · Allergo Journal International · doi:10.1007/s40629-020-00118-6 · Cited by 57
Self-citationUnderstanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases
Jiménez‐Saiz, R., Iborra, S., Blanco, C., González‐Pérez, R., Nuñez‐Borque, E., Zeyneloglu, C., Babayev, H., Göksel, O., Göksel, T., Khaitov, M., et al. (2026) · Allergy · doi:10.1111/all.70512 · Cited by 2
Metadata
- Authors
- Marichal, T., Starkl, P., Reber, L. L., Kalesnikoff, J., Oettgen, H. C., Tsai, M., Metz, M., & Galli, S. J.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 39
- Issue
- 5
- Pages
- 963-975
- ISSN
- 1074-7613
- PMC
- PMC4164235
- Cited by
- 180
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
